InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: Markipeach post# 205332

Friday, 08/02/2019 1:52:20 PM

Friday, August 02, 2019 1:52:20 PM

Post# of 425795
We had no information to suggest JT was this incompetent before the capital raise.

There were some questionable decisions made before this (and some really good things management did like getting Mochida not to dispute their IP).

1. The decision to stop appealing anchor all the way up the FDA chain so they could then sue the FDA in federal court for breach of contract and damages. I think they should have done this. The court might not have approved the label (saying such was beyond their competence) but I think the court would have ordered the government to make good their financial losses for breaching the SPA contract.

2. The ITC suit... predictably the ITC and FDA didn't want to go to war with dietary supplement makers (a war they would almost certainly lose).

But raising this much money now... and for... sales reps. And he is going to wait to do DTC ads until this Office of Prescription Drug Promotion approves rather then ignoring them and asserting the companies 1st amendment rights... makes me think hes incompetent. Perhaps competent enough for the Reduce-It auto pilot phase but as far as the drug launch in over his head.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News